

$29.12K
1
1
1 market tracked
No data available
| Market | Platform | Price |
|---|---|---|
Will Trump make IVF free? | Kalshi | 15% |
Trader mode: Actionable analysis for identifying opportunities and edge
Before his term ends If the President takes an action that eliminates the cost of at least one IVF cycle before Jan 20, 2029, then the market resolves to Yes. Early close condition: This market will close and expire early if the event occurs. This market will close and expire early if the event occurs.
Prediction markets currently give Donald Trump about a 15% chance of making at least one cycle of in-vitro fertilization (IVF) free before January 2029. In simple terms, traders see this as unlikely, estimating roughly a 1 in 7 chance it will happen. This reflects a low level of confidence that a major federal policy eliminating the cost of IVF will be enacted during a potential Trump presidency.
The low probability stems from a few clear factors. First, while IVF access became a national political issue after the 2022 Dobbs decision, federal policy has not moved toward making it free. IVF is expensive, often costing $15,000 to $30,000 per cycle, and is typically paid for out-of-pocket or through variable insurance coverage.
Second, Trump’s own policy statements have focused on protecting access to IVF, not on federal funding to eliminate its cost. He has encouraged states to take action and said he supports IVF availability, but he has not proposed a national program to pay for it. Historically, major new federal entitlements or health benefits require specific legislation and funding, a high bar in a divided Congress.
Finally, the political incentives may not align. While supporting IVF is popular, the specific policy of making it “free” through federal action would involve complex debates over government spending, insurance mandates, and the role of states, making it a less likely priority compared to other healthcare or economic issues.
The main timeline runs through January 20, 2029. Watch for any proposed legislation in Congress that specifically allocates federal funding to cover IVF costs. The party platforms released at the 2024 Republican and Democratic conventions may offer clues. If Trump wins the election, his first 100 days in office in 2025 and the release of his detailed budget proposal would be critical periods to see if a funded IVF plan emerges. Significant shifts could also come from unexpected court rulings or state-level laws that increase pressure for a federal response.
Prediction markets are generally useful for aggregating collective judgment on political outcomes, but they are less tested on highly specific policy questions like this one. Markets have a good track record on binary election results, but a niche policy bet with lower trading volume can be more sensitive to news headlines. The 15% probability is a real-time snapshot of informed opinion, but it should be seen as a gauge of current expectations, not a sure forecast. The biggest limitation is that the event is several years away and depends on legislative action, which is inherently unpredictable.
Prediction markets assign a 15% probability that former President Donald Trump will eliminate the cost of at least one IVF cycle before January 20, 2029. This price indicates the market views the policy as improbable. With only $29,000 in volume, liquidity is thin, meaning a single large trade could shift the odds significantly. A 15% chance suggests traders see a plausible but unlikely scenario, pricing it as a long-shot bet rather than a core expectation.
The low probability reflects Trump's established policy record and current political rhetoric. During his presidency, his administration's primary healthcare focus was repealing the Affordable Care Act, not expanding federal coverage for specific procedures like IVF. His 2024 campaign platform and public statements have centered on immigration, the economy, and energy, with no detailed proposal for federally funded fertility treatments. Furthermore, the Republican Party platform has historically emphasized limited government intervention in healthcare and contains language supporting fetal personhood, a concept that can conflict with IVF practices involving embryo creation or disposal. The market is pricing in this ideological and policy misalignment.
A major shift in Trump's public stance would be necessary to move this market. An explicit campaign promise to provide free IVF, embedded in a major policy speech or formal platform document, would likely cause the probability to spike. Conversely, a clarifying statement rejecting federal funding for IVF could drive the price toward zero. The market may also react to external events, such as a Supreme Court decision directly restricting IVF access, which could increase political pressure for a federal response. However, given the current policy landscape and the high estimated cost of such a program, the consensus view of low probability appears well-founded. Traders should watch for any detailed policy white papers from the campaign ahead of the election or during a potential second term.
AI-generated analysis based on market data. Not financial advice.
This prediction market addresses whether former President Donald Trump will implement a policy making in vitro fertilization (IVF) free for at least one cycle before January 20, 2029. IVF is a medical procedure where an egg is fertilized by sperm outside the body, and the resulting embryo is transferred to a uterus. The average cost of a single IVF cycle in the United States is approximately $12,000 to $15,000, with many patients requiring multiple cycles for a successful pregnancy. This financial barrier places the treatment out of reach for many Americans without insurance coverage or significant personal savings. The topic gained political prominence following the Alabama Supreme Court's February 2024 ruling that frozen embryos are considered children under state law, which temporarily halted IVF services in the state and ignited a national debate about reproductive technology access. President Joe Biden and Democrats have since emphasized protecting IVF access, while some Republicans, including Trump, have expressed support for the treatment but have not unified behind specific federal policy proposals. The question of whether Trump would make IVF free connects to broader discussions about healthcare affordability, reproductive rights, and the role of federal policy in subsidizing medical treatments. It also tests Trump's willingness to break from some factions within his party that hold more restrictive views on assisted reproductive technology based on embryo personhood arguments. Political observers are watching whether Trump will propose concrete policy, such as a federal mandate for insurance coverage or a subsidy program, to address IVF costs as part of his 2024 campaign platform or potential second-term agenda.
The political debate over IVF access has roots in decades of conflict over reproductive technology and embryo status. The first successful IVF birth in the United States occurred in 1981, just three years after the first worldwide in 1978. For most of its history, IVF was primarily a medical and financial issue rather than a political one. This changed in the 1990s as the anti-abortion movement expanded its focus to include embryonic research and assisted reproductive technologies. In 1996, Congress passed the Dickey-Wicker Amendment, which prohibits federal funding for research that creates or destroys human embryos. This restriction has limited government involvement in IVF development and regulation. The 2008 election marked a turning point when both major party presidential candidates, Barack Obama and John McCain, expressed support for federal funding for embryonic stem cell research, which is closely related to IVF debates. More recently, state-level actions have forced the issue onto the national stage. In 2015, then-candidate Donald Trump initially described himself as 'pro-life' but expressed support for IVF during a CNN town hall, stating 'I have many friends that have had that situation, and I'm all for it.' The Alabama Supreme Court's 2024 ruling represented the most significant judicial intervention into IVF, applying the state's Wrongful Death of a Minor Act to frozen embryos and creating immediate legal uncertainty for clinics and patients. This decision followed the 2022 Dobbs v. Jackson Women's Health Organization ruling that overturned Roe v. Wade, which empowered states to regulate reproductive matters more strictly and raised questions about how far personhood arguments might extend beyond abortion.
The question of making IVF free has significant implications for American families, healthcare systems, and political coalitions. Approximately one in eight U.S. couples experiences infertility, translating to millions of potential patients who face substantial out-of-pocket costs for treatment. Making IVF free would dramatically expand access to family building for middle-class Americans who currently cannot afford the procedure, potentially affecting demographic trends and family formation patterns. Financially, such a policy would represent a major new healthcare expenditure, whether funded through insurance mandates, tax credits, or direct federal spending. The political ramifications extend beyond reproductive rights to questions about healthcare economics and the role of government in subsidizing medical treatments. Some conservatives who oppose abortion but support IVF face internal party tension, as personhood arguments that protect embryos could logically extend to restrict common IVF practices like embryo freezing, genetic testing, or selective transfer. The insurance industry would be directly affected by any mandate to cover IVF, potentially increasing premiums while expanding coverage. Employers, particularly those who self-insure, would face new benefit requirements. For the medical community, free IVF could increase patient volume but might come with regulatory strings attached regarding embryo handling and reporting requirements. Downstream consequences could include increased demand for fertility specialists, potential strain on clinic capacity, and ethical debates about how many cycles should be covered or whether there should be age or medical criteria for access.
Educational content is AI-generated and sourced from Wikipedia. It should not be considered financial advice.
No related news found
Add this market to your website
<iframe src="https://predictpedia.com/embed/zmztT_" width="400" height="160" frameborder="0" style="border-radius: 8px; max-width: 100%;" title="Will Trump make IVF free?"></iframe>